首页> 美国卫生研究院文献>The FASEB Journal >ChIP-on-chip analysis reveals angiopoietin 2 (Ang2 ANGPT2) as a novel target of steroidogenic factor-1 (SF-1 NR5A1) in the human adrenal gland
【2h】

ChIP-on-chip analysis reveals angiopoietin 2 (Ang2 ANGPT2) as a novel target of steroidogenic factor-1 (SF-1 NR5A1) in the human adrenal gland

机译:芯片上芯片分析显示血管生成素2(Ang2ANGPT2)是人类肾上腺中类固醇生成因子-1(SF-1NR5A1)的新型靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The nuclear receptor steroidogenic factor-1 (SF-1, NR5A1) is a key regulator of adrenal and gonadal biology. Disruption of SF-1 can lead to disorders of adrenal development, while increased SF-1 dosage has been associated with adrenocortical tumorigenesis. We aimed to identify a novel subset of SF-1 target genes in the adrenal by using chromatin immunoprecipitation (ChIP) microarrays (ChIP-on-chip) combined with systems analysis. SF-1 ChIP-on-chip was performed in NCI-H295R human adrenocortical cells using promoter tiling arrays, leading to the identification of 445 gene loci where SF-1-binding regions were located from 10 kb upstream to 3 kb downstream of a transcriptional start. Network analysis of genes identified as putative SF-1 targets revealed enrichment for angiogenic process networks. A 1.1-kb SF-1-binding region was identified in the angiopoietin 2 (Ang2, ANGPT2) promoter in a highly repetitive region, and SF-1-dependent activation was confirmed in luciferase assays. Angiogenesis is paramount in adrenal development and tumorigenesis, but until now a direct link between SF-1 and vascular remodeling has not been established. We have identified Ang2 as a potentially important novel target of SF-1 in the adrenal gland, indicating that regulation of angiogenesis might be an important additional mechanism by which SF-1 exerts its actions in the adrenal gland.—Ferraz-de-Souza, B., Lin, L., Shah, S., Jina, N., Hubank, M., Dattani, M. T., Achermann, J. C. ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland.
机译:核受体类固醇生成因子-1(SF-1,NR5A1)是肾上腺和性腺生物学的关键调节剂。 SF-1的破坏可导致肾上腺发育异常,而SF-1剂量增加已与肾上腺皮质肿瘤发生有关。我们旨在通过使用染色质免疫沉淀(ChIP)微阵列(芯片上芯片)结合系统分析来识别肾上腺中SF-1靶基因的新子集。使用启动子切片阵列在NCI-H295R人肾上腺皮质细胞中进行了SF-1 ChIP芯片化,从而鉴定了445个基因位点,其中SF-1结合区位于转录的上游10 kb至下游的3 kb。开始。对确定为假定的SF-1靶标的基因进行网络分析,发现其丰富了血管生成过程网络。在高度重复区域的血管生成素2(Ang2,ANGPT2)启动子中鉴定到一个1.1-kb SF-1结合区,并在荧光素酶测定中证实了SF-1依赖性激活。血管生成在肾上腺发育和肿瘤发生中至关重要,但是到目前为止,SF-1与血管重塑之间没有直接联系。我们已经确定Ang2是肾上腺SF-1的潜在重要新靶标,这表明血管生成的调控可能是SF-1在肾上腺发挥作用的重要附加机制。-Ferraz-de-Souza, B.,Lin,L.,Shah,S.,Jina,N.,Hubank,M.,Dattani,MT,Achermann,JC芯片上芯片分析显示血管生成素2(Ang2,ANGPT2)是类固醇生成的新靶标人肾上腺中的因子-1(SF-1,NR5A1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号